Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review.

Szczegóły
Abstrakt

Tytuł:: Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review.
Autorzy:: Duong-Thi-Ly H; 1 School of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam.
Nguyen-Thi-Thu H; 1 School of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam.
Nguyen-Hoang L; 1 School of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam.
Nguyen-Thi-Bich H; 2 Department of Immunology, Allergology, and Rheumatology, National Hospital of Paediatrics, Hanoi, Vietnam.
Craig TJ; 3 Department of Medicine, Penn State University, Hershey, PA, USA.
Duong-Quy S; 3 Department of Medicine, Penn State University, Hershey, PA, USA.; 4 Department of Pulmonology, Hospital Cochin, Paris Descartes University, Paris, France.; 5 Department of Respiratory Diseases, Medical-Biological Research Centre, Lam Dong Medical College, Dalat, Vietnam.
Źródło:: The Journal of international medical research [J Int Med Res] 2017 Dec; Vol. 45 (6), pp. 1818-1830. Date of Electronic Publication: 2017 Jan 25.
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Publication: Nov. 2012- : London : Sage Publications
Original Publication: Northampton, Eng., Cambridge Medical Publications ltd.
MeSH Terms:: Genetic Predisposition to Disease*
Adrenal Cortex Hormones/*administration & dosage
Adrenal Cortex Hormones/*therapeutic use
Asthma/*drug therapy
Asthma/*genetics
Administration, Inhalation ; Child ; Humans ; Pneumonia/complications ; Pneumonia/drug therapy ; Polymorphism, Single Nucleotide/genetics
References:: Pharmacogenomics J. 2006 Sep-Oct;6(5):311-26. (PMID: 16568148)
J Allergy Clin Immunol. 2009 Sep;124(3):422-7. (PMID: 19665766)
Am J Respir Crit Care Med. 2006 Jan 1;173(1):64-70. (PMID: 16179640)
Mol Cancer Res. 2008 Apr;6(4):624-33. (PMID: 18403641)
Biologics. 2013;7:199-210. (PMID: 24009412)
J Clin Invest. 2008 Nov;118(11):3546-56. (PMID: 18982161)
Ann Intern Med. 2003 Sep 2;139(5 Pt 1):359-70. (PMID: 12965945)
J Clin Pharm Ther. 2009 Dec;34(6):693-701. (PMID: 20175803)
Pediatrics. 1993 Oct;92(4):535-40. (PMID: 8414823)
J Allergy Clin Immunol. 2009 Jun;123(6):1376-83.e7. (PMID: 19254810)
Ann Thorac Med. 2010 Jul;5(3):133-9. (PMID: 20835306)
J Immunol. 2010 Sep 15;185(6):3489-97. (PMID: 20702731)
N Engl J Med. 2010 Sep 23;363(13):1211-1221. (PMID: 20860503)
N Engl J Med. 2010 Jan 7;362(1):36-44. (PMID: 20032318)
J Allergy Clin Immunol. 2007 Dec;120(6):1285-91. (PMID: 17980418)
J Allergy Clin Immunol. 1989 May;83(5):875-82. (PMID: 2715548)
J Allergy Clin Immunol. 1994 Aug;94(2 Pt 1):222-30. (PMID: 8064074)
Nature. 2007 Jul 26;448(7152):470-3. (PMID: 17611496)
Lancet. 2004 Feb 28;363(9410):731-3. (PMID: 15001333)
J R Soc Med. 2010 Mar;103(3):98-106. (PMID: 20200181)
Respir Res. 2006 Feb 06;7:21. (PMID: 16460559)
Pharmacogenomics J. 2011 Dec;11(6):383-92. (PMID: 21987090)
Genes Cancer. 2011 Dec;2(12):1097-105. (PMID: 22866201)
Trends Endocrinol Metab. 2008 Jan;19(1):32-8. (PMID: 18155557)
Nature. 2010 Feb 25;463(7284):1048-53. (PMID: 20182505)
Cent Eur J Immunol. 2015;40(3):325-30. (PMID: 26648776)
Eur Respir J. 2006 Feb;27(2):413-26. (PMID: 16452600)
Pediatr Pulmonol. 2000 Apr;29(4):250-6. (PMID: 10738011)
J Allergy Clin Immunol. 2001 Feb;107(2):295-301. (PMID: 11174196)
Pediatrics. 2006 Aug;118(2):e347-55. (PMID: 16864642)
Allergy. 2011 Dec;66(12):1546-52. (PMID: 21958076)
Pharmacogenomics J. 2013 Dec;13(6):523-9. (PMID: 22986918)
Pharmacogenomics. 2009 Aug;10(8):1231-42. (PMID: 19663668)
J Allergy Clin Immunol. 2010 Sep;126(3):618-25.e1-2. (PMID: 20673984)
Eur J Pediatr. 2011 Jun;170(6):709-18. (PMID: 20931226)
Allergy. 2014 Feb;69(2):231-6. (PMID: 24354852)
Clin Exp Allergy. 2011 Mar;41(3):312-26. (PMID: 21294785)
J Allergy Clin Immunol. 2004 Nov;114(5):1093-9. (PMID: 15536415)
Per Med. 2011 Jan;8(1):59-70. (PMID: 21660115)
J Biol Chem. 2005 Oct 7;280(40):34178-85. (PMID: 16100115)
Sci Rep. 2013 Oct 10;3:2915. (PMID: 24107858)
J Allergy Clin Immunol. 2008 Mar;121(3):580-4. (PMID: 18234319)
Am J Respir Crit Care Med. 2012 Jun 15;185(12):1286-91. (PMID: 22538805)
Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18099-104. (PMID: 15604153)
Clin Exp Allergy. 2015 Mar;45(3):624-31. (PMID: 25411998)
Mol Diagn Ther. 2012 Jun 1;16(3):173-80. (PMID: 22519966)
J Endocrinol. 2003 Sep;178(3):347-55. (PMID: 12967328)
Korean J Intern Med. 2013 Nov;28(6):708-14. (PMID: 24307847)
Eur Respir J. 2005 Mar;25(3):552-63. (PMID: 15738302)
Drug News Perspect. 2008 Mar;21(2):89-96. (PMID: 18389100)
Indian J Med Res. 2015 Dec;142(6):640-3. (PMID: 26831411)
N Engl J Med. 2011 Sep 29;365(13):1173-83. (PMID: 21991891)
Hum Mol Genet. 2004 Jul 1;13(13):1353-9. (PMID: 15128701)
Contributed Indexing:: Keywords: Corticoids; asthma; children; gene; inhaled corticosteroid
Substance Nomenclature:: 0 (Adrenal Cortex Hormones)
Entry Date(s):: Date Created: 20171219 Date Completed: 20180723 Latest Revision: 20181113
Update Code:: 20240104
PubMed Central ID:: PMC5805193
DOI:: 10.1177/0300060516683877
PMID:: 29251255
: Czasopismo naukowe

Full Text Finder

Numerous studies have examined the association between pharmacogenetic effects and the response to inhaled corticosteroids (ICS) in patients with asthma. In fact, several single nucleotide polymorphisms of a number of candidate genes have been identified that might influence the clinical response to ICS in children with asthma. Their direct or indirect effects depend on their role in the inflammatory process in asthma or the anti-inflammatory action of corticosteroids, respectively. Among the genes identified, variants in T-box 21 ( TBX21) and Fc fragment of IgE receptor II ( FCER2) contribute indirectly to the variability in the response to ICS by altering the inflammatory mechanisms in asthma, while other genes such as corticotropin releasing hormone receptor 1 ( CRHR1), nuclear receptor subfamily 3 group C member 1 ( NR3C1), stress induced phosphoprotein 1 ( STIP1), dual specificity phosphatase 1 (DUSP1), glucocorticoid induced 1 (GLCCI1), histone deacetylase 1 (HDAC), ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3), and vascular endothelial growth factors (VEGF) directly affect this variability through the anti-inflammatory mechanisms of ICS. The results to date indicate various potential genetic factors associated with the response to ICS, which could be utilized to predict the individual therapeutic response of children with asthma to ICS. Clinical trials are underway and their results are greatly anticipated. Further pharmacogenetic studies are needed to fully understand the effects of genetic variation on the response to ICS in children with asthma.

Informacja